Humberto C. Antunes, Galderma worldwide CEO, was awarded a Lifetime in Dermatology Achievement from the Journal of Drugs in Dermatology (JDD) at the Orlando Dermatology Aesthetic & Clinical (ODAC) Conference.
In 2013, the JDD requested nominations from the entire dermatology community, including the JDD editorial board, authors, and reviewers, for those companies regarded among their peers as the very best thought leaders in a particular dermatology specialty.
Galderma was elected to receive a prestigious JDD Leaders of Distinction Award and chosen as the Leader of Distinction for the ‘Lifetime in Dermatology Achievement Award’.
‘Galderma is one of the world’s leading pharmaceutical companies in dermatology, and also one of the most generous, much of which would not be possible without Humberto Antunes’ leadership, dedication and philanthropy to the industry,’ said Dr Robins, ODAC Conference Chair Emeritus and Professor Emeritus of Dermatology at NYU School of Medicine.
‘I have had the pleasure of knowing Humberto for many, many years and in that vein, it gives me great pleasure to honor him with the Journal of Drugs in Dermatology ‘Lifetime in Dermatology Achievement Award,’ and know that he will continue to positively shape the future of dermatology,’ Dr Robins added.
Following receipt of the award, Antunes also served as the ODAC key note speaker, presenting his vision of the ‘Future of Dermatology’ and addressing questions from health professionals.
Antunes is a Brazilian-born, Swiss-based dermatology veteran with 30 years of experience. He has been with Galderma for 17 years.
